About BioMed Realty
BioMed Realty, a Blackstone Real Estate portfolio company, is a leading provider of real estate solutions to the life science and technology industries. It owns and manages 16.1 million square feet of high-quality life science properties in major markets across the United States, including Boston/Cambridge.
Why They Are a 2024 Climate Leader
BioMed Realty, a Blackstone Real Estate portfolio company, leads a globally renowned real estate portfolio wherein they own and operate multiple Class A life science facilities totaling an exceptional 16 million square feet of property. Central to BioMed Realty’s business model is a deep-rooted sense of corporate responsibility that goes beyond providing state-of-the-art sustainable buildings, labs, and infrastructure to support growth and development in the life science sector. BioMed Realty expresses a clear fiduciary commitment to systematically address and manage Environmental, Social and Governance (ESG) and climate-related risks as an integral part of its corporate thinking, operations, and governance.
As a part of its decarbonization plan, the Company has committed all new developments to be LEED Silver certified at a minimum. BioMed has also been awarded for its commitment to energy efficiency and sustainability in the past through attaining LEED Platinum and Gold certifications at its properties. BioMed Realty currently has a total of 5.2 million square feet of LEED certified buildings, earning them a Top 5 Star Rating in the 2023 GRESB Real Estate Assessment, the premier global standard for assessing ESG performance in real estate and infrastructure investments.
A notable example in its portfolio is The Center for Life Science Boston, a 700,000+ square foot research center, in which the Company was awarded a LEED Gold certification for this property. BioMed was also awarded the AIA 2004 Excellence in Sustainable Design Award and the AIA COTE 2004 Top Ten Green Projects Award for The Center for Life Science in Boston. The Company reduced energy consumption at this location by nearly 1,500,000 kWh annually through an extensive chiller plant optimization project, as well as by implementing cutting edge SmartStack Technology to reduce laboratory exhaust airflow. Several other SmartStack upgrades have been leveraged across its portfolio, as well as new large-scale heat pump technology, exemplifying the Company’s ongoing commitment to state-of-the-art energy efficient upgrades.
Another featured property is 301 Binney Street located in Cambridge, MA, in which they achieved an impressive 500,000 kWh in annual savings through chiller plant optimization. A leader in the industry of life science real estate, BioMed Realty continues to explore further strategies and solutions to decarbonize its portfolio in years to come the future.
